| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.213 | 7.859 | 25.120 | 19.855 | 20.639 | 14.470 |
| Total Income - EUR | - | - | - | - | 5.213 | 7.859 | 25.121 | 19.855 | 20.639 | 15.895 |
| Total Expenses - EUR | - | - | - | - | 1.914 | 959 | 6.294 | 9.121 | 11.957 | 13.076 |
| Gross Profit/Loss - EUR | - | - | - | - | 3.300 | 6.900 | 18.827 | 10.735 | 8.683 | 2.819 |
| Net Profit/Loss - EUR | - | - | - | - | 3.143 | 6.680 | 18.073 | 10.139 | 7.047 | 2.125 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ghemidrag Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 33 | 0 | 16.157 | 12.467 | 10.022 | 6.413 |
| Current Assets | - | - | - | - | 3.252 | 9.931 | 14.095 | 2.626 | 3.714 | 9.678 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 442 | 2.501 | 992 | 287 |
| Cash | - | - | - | - | 3.252 | 9.931 | 13.653 | 126 | 2.722 | 9.391 |
| Shareholders Funds | - | - | - | - | 3.185 | 9.805 | 27.661 | 6.459 | 13.486 | 15.536 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 99 | 126 | 2.592 | 8.634 | 250 | 555 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ghemidrag Med S.r.l.